VAXART INC revenue breakdown overview

VAXART INC revenue for the last year amounted to 598.38 M MXN, the most of which — 598.38 M MXN — came from its highest performing source at the moment, Oral Recombinant Protein Vaccines, the year earlier bringing 125.33 M MXN. The greatest contribution to the revenue figure was made by United States — last year it brought VAXART INC 598.38 M MXN, and the year before that — 125.33 M MXN.